ELVN Competitors & Alternatives
Compare Enliven Therapeutics Inc. with similar stocks in the same industry
Biotechnology
ELVN
Main Stock$40.75
Tradestie Score
55
Market Cap
$1.17B
Analyst Upside
+25.9%
Top Competitors
224 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CPRX
Catalyst Pharmaceutical Inc.
|
$31.15
|
$2.56B | 18.6 | 63 | Compare |
|
CDTX
Cidara Therapeutics, Inc.
|
$221.38
|
$2.44B | - | 57 | Compare |
|
BEAM
Beam Therapeutics Inc. Common Stock
|
$32.32
|
$2.44B | - | 63 | Compare |
|
TARS
Tarsus Pharmaceuticals, Inc. Common Stock
|
$61.21
|
$2.42B | - | 56 | Compare |
|
BLTE
Belite Bio, Inc American Depositary Shares
|
$154.88
|
$2.41B | - | 53 | Compare |
|
IDYA
IDEAYA Biosciences, Inc. Common Stock
|
$28.32
|
$2.40B | - | 55 | Compare |
|
FOLD
Amicus Therapeutics, Inc
|
$14.49
|
$2.38B | - | 60 | Compare |
|
ARQT
Arcutis Biotherapeutics, Inc. Common Stock
|
$21.17
|
$2.37B | - | 61 | Compare |
|
APGE
Apogee Therapeutics, Inc. Common Stock
|
$83.03
|
$2.35B | - | 55 | Compare |
|
IBRX
ImmunityBio, Inc. Common Stock
|
$8.51
|
$2.34B | - | 58 | Compare |
More ELVN Analysis
Data updated: May 09, 2026 | Industry: Biotechnology (SIC 2834)
224 stocks in this industry